| Year |
Citation |
Score |
| 2023 |
Goda C, Kolovich S, Rudich A, Karunasiri M, Kulkarni R, Rajgolikar G, Neidemire-Colley L, Singh S, Sircar A, Ranganathan P, Garzon R, Sehgal L, Dorrance AM. Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma. Experimental Hematology. PMID 37209901 DOI: 10.1016/j.exphem.2023.05.003 |
0.31 |
|
| 2021 |
Bill M, Goda C, Pepe F, Ozer HG, McNeil B, Zhang X, Karunasiri M, Kulkarni R, Kalyan S, Papaioannou D, Ferenchak G, Garzon R, Bradner JE, Marcucci G, Caligiuri MA, ... Dorrance AM, et al. Targeting BRD4 in acute myeloid leukemia with partial tandem duplication of the gene. Haematologica. PMID 33979989 DOI: 10.3324/haematol.2020.271627 |
0.469 |
|
| 2020 |
Papaioannou D, Volinia S, Nicolet D, Świerniak M, Petri A, Mrózek K, Bill M, Pepe F, Walker CJ, Walker AE, Carroll AJ, Kohlschmidt J, Eisfeld AK, Powell BL, Uy GL, ... ... Dorrance A, et al. Clinical and functional significance of circular RNAs in cytogenetically normal AML. Blood Advances. 4: 239-251. PMID 31945158 DOI: 10.1182/Bloodadvances.2019000568 |
0.368 |
|
| 2019 |
Papaioannou D, Petri A, Dovey OM, Terreri S, Wang E, Collins FA, Woodward LA, Walker AE, Nicolet D, Pepe F, Kumchala P, Bill M, Walker CJ, Karunasiri M, Mrózek K, ... ... Dorrance AM, et al. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. Nature Communications. 10: 5351. PMID 31767858 DOI: 10.1038/S41467-019-13259-2 |
0.339 |
|
| 2019 |
Bill M, Pathmanathan A, Karunasiri M, Shen C, Burke MH, Ranganathan P, Papaioannou D, Zitzer NC, Snyder K, LaRocco A, Walker AE, Brannan ZJ, Nalin AP, Freud AG, Dikov MM, ... ... Dorrance AM, et al. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31672772 DOI: 10.1158/1078-0432.Ccr-19-2479 |
0.645 |
|
| 2019 |
Bill M, Nicolet D, Kohlschmidt J, Walker CJ, Mrózek K, Eisfeld AK, Papaioannou D, Rong-Mullins X, Brannan Z, Kolitz JE, Powell BL, Archer KJ, Dorrance AM, Carroll AJ, Stone RM, et al. Mutations associated with a 17-gene leukemia stem cell score and its prognostic relevance in the context of the European LeukemiaNet classification for acute myeloid leukemia. Haematologica. PMID 31413100 DOI: 10.3324/Haematol.2019.225003 |
0.398 |
|
| 2019 |
Bill M, Papaioannou D, Karunasiri M, Kohlschmidt J, Pepe F, Walker CJ, Walker AE, Brannan Z, Pathmanathan A, Zhang X, Mrózek K, LaRocco A, Volinia S, Bloomfield CD, Garzon R, ... Dorrance AM, et al. Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells. Leukemia. PMID 30858548 DOI: 10.1038/S41375-019-0429-5 |
0.452 |
|
| 2019 |
Bill M, Pathmanathan A, Karunasiri M, Shen C, Burke M, Ranganathan P, Papaioannou D, Zitzer NC, Snyder K, LaRocco A, Walker A, Brannan Z, Nalin AP, Freud AG, Dikov M, ... ... Dorrance AM, et al. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia (AML) Blood. 134: 2546-2546. DOI: 10.1182/Blood-2019-131856 |
0.635 |
|
| 2019 |
Papaioannou D, Buisson R, Petri A, Walker A, Bill M, Pepe F, Nicolet D, Woodward LA, Mrózek K, Karunasiri M, Behbehani GK, Cocucci E, Singh G, Kauppinen S, Dorrance AM, et al. CircPCMTD1: A Protein-Coding Circular RNA That Regulates DNA Synthesis in Leukemic Myeloblasts Blood. 134: 640-640. DOI: 10.1182/Blood-2019-126223 |
0.33 |
|
| 2018 |
Lovat F, Fassan M, Sacchi D, Ranganathan P, Palamarchuk A, Bill M, Karunasiri M, Gasparini P, Nigita G, Distefano R, Veneziano D, Dorrance AM, Garzon R, Croce CM. Knockout of both miR-15/16 loci induces acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. PMID 30478046 DOI: 10.1073/Pnas.1814980115 |
0.36 |
|
| 2018 |
Mani R, Goswami S, Gopalakrishnan B, Ramaswamy R, Wasmuth R, Tranh M, Mo X, Gordon A, Bucci D, Lucas DM, Mims A, Brooks C, Dorrance A, Walker A, Blum W, et al. The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34CD123 cells from acute myeloid leukemia / myelodysplastic syndrome patients and healthy donors. Haematologica. PMID 29773600 DOI: 10.3324/Haematol.2018.188193 |
0.432 |
|
| 2018 |
Zhang B, Nguyen LXT, Li L, Zhao D, Kumar B, Wu H, Lin A, Pellicano F, Hopcroft L, Su YL, Copland M, Holyoake TL, Kuo CJ, Bhatia R, Snyder DS, ... ... Dorrance A, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nature Medicine. PMID 29505034 DOI: 10.1038/Nm.4499 |
0.38 |
|
| 2018 |
Bill M, Veneziano D, Kohlschmidt J, Mrózek K, Nigita G, Krantz MG, Nicolet D, Papaioannou D, Walker A, Brannan Z, Powell BL, Stone RM, Uy GL, Kolitz JE, Wang ES, ... Dorrance AM, et al. Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) Blood. 132: 89-89. DOI: 10.1182/Blood-2018-99-115270 |
0.346 |
|
| 2018 |
Papaioannou D, Petri A, Terreri S, Thrue CA, Nicolet D, Collins FA, Woodward LA, Kumchala P, Karunasiri M, Pepe F, Bill M, Zitzer N, Singh G, Kaupinnen S, Bloomfield CD, ... Dorrance AM, et al. Abstract 519: The long non-coding RNA (lncRNA) HOXB-AS3 regulates transcription of ribosomal RNA (rRNA) in NPM1-mutated (NPM1mut) acute myeloid leukemia (AML) Cancer Research. 78: 519-519. DOI: 10.1158/1538-7445.Am2018-519 |
0.429 |
|
| 2018 |
Bill M, Karunasiri M, Kohlschmidt J, Walker AE, Brannan Z, Volinia S, Bloomfield CD, Garzon R, Dorrance AM. Abstract 2455: The long non-coding RNA (lncRNA) DANCR in acute myeloid leukemia (AML) stem cells (LSC) Cancer Research. 78: 2455-2455. DOI: 10.1158/1538-7445.Am2018-2455 |
0.41 |
|
| 2017 |
Papaioannou D, Shen C, Nicolet D, McNeil B, Bill M, Karunasiri M, Burke MH, Ozer HG, Yilmaz SA, Zitzer N, Behbehani GK, Oakes CC, Steiner DJ, Marcucci G, Powell BL, ... ... Dorrance AM, et al. Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. PMID 28533390 DOI: 10.1073/Pnas.1703142114 |
0.56 |
|
| 2017 |
He Z, Hu X, Liu W, Dorrance A, Garzon R, Houghton PJ, Shen C. P53 suppresses ribonucleotide reductase via inhibiting mTORC1. Oncotarget. PMID 28507282 DOI: 10.18632/Oncotarget.17440 |
0.41 |
|
| 2017 |
Zhou X, Liu W, Hu X, Dorrance A, Garzon R, Houghton PJ, Shen C. Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells. Scientific Reports. 7: 1535. PMID 28484242 DOI: 10.1038/S41598-017-01729-W |
0.326 |
|
| 2017 |
Bill M, Karunasiri M, Burke M, Walker A, Volinia S, Bloomfield C, Garzon R, Dorrance A. Elucidating the role of the long non-coding RNA dancr in leukemic stem cells in acute myeloid leukemia (AML) Experimental Hematology. 53. DOI: 10.1016/J.Exphem.2017.06.312 |
0.367 |
|
| 2016 |
Leoncini PP, Bertaina A, Papaioannou D, Flotho C, Masetti R, Bresolin S, Menna G, Santoro N, Zecca M, Basso G, Nigita G, Veneziano D, Pagotto S, D'Ovidio K, Rota R, ... Dorrance A, et al. MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment. Oncotarget. PMID 27447965 DOI: 10.18632/Oncotarget.10577 |
0.39 |
|
| 2016 |
Ranganathan P, Kashyap T, Yu X, Meng X, Lai TH, McNeil B, Bhatnagar B, Shacham S, Kauffman M, Dorrance AM, Blum W, Sampath D, Landesman Y, Garzon R. XPO1 Inhibition Using Selinexor Synergizes With Chemotherapy in Acute Myeloid Leukemia (AML) by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27358488 DOI: 10.1158/1078-0432.Ccr-15-2885 |
0.367 |
|
| 2016 |
Shen C, Papaioannou D, Mcneil B, Nicolet D, Karunasiri M, Burke M, Nina Z, Behbehani GK, Ozer HG, Yilmaz S, Marcucci G, Caligiuri MA, Bloomfield CD, Garzon R, Dorrance A. EGFL7 Antagonizes NOTCH Signaling, Stimulates Blast Proliferation and Confers Poor Prognosis in Cytogenetically-Normal Acute Myeloid Leukemia (CN-AML) Blood. 128: 2689-2689. DOI: 10.1182/Blood.V128.22.2689.2689 |
0.579 |
|
| 2016 |
Papaioannou D, Petri A, Thrue CA, Volinia S, Kroll K, Pearlly Y, Bundschuh R, Singh G, Kauppinen S, Bloomfield CD, Dorrance A, Garzon R. HOXB-AS3 Regulates Cell Cycle Progression and Interacts with the Drosophila Splicing Human Behavior (DSHB) Complex in NPM1-Mutated Acute Myeloid Leukemia Blood. 128: 1514-1514. DOI: 10.1182/Blood.V128.22.1514.1514 |
0.477 |
|
| 2015 |
Dorrance AM, Neviani P, Ferenchak GJ, Huang X, Nicolet D, Maharry KS, Ozer HG, Hoellarbauer P, Khalife J, Hill EB, Yadav M, Bolon BN, Lee RJ, Lee LJ, Croce CM, et al. Targeting leukemia stem cells in vivo with ANTAGOMIR-126 nanoparticles in acute myeloid leukemia. Leukemia. PMID 26055302 DOI: 10.1038/Leu.2015.139 |
0.548 |
|
| 2015 |
Ozer HG, Usubalieva A, Dorrance A, Yilmaz AS, Caligiuri M, Marcucci G, Huang K. Identification of medium-sized copy number alterations in whole-genome sequencing. Cancer Informatics. 13: 105-11. PMID 25788829 DOI: 10.4137/Cin.S14023 |
0.415 |
|
| 2015 |
Zhang B, Li L, Chen C, Stein AS, Ali H, Snyder DS, Lin A, Dorrance A, Swiderski P, Bhatia R, Perrotti D, Forman SJ, Kuo Y, Kortylewski M, Marcucci G. Knockdown (KD) of Mir-126 Expression Enhances Tyrosine Kinase Inhibitor (TKI)-Mediated Targeting of Chronic Myelogenous Leukemia (CML) Stem Cells Blood. 126: 51-51. DOI: 10.1182/Blood.V126.23.51.51 |
0.405 |
|
| 2014 |
Alachkar H, Santhanam R, Maharry K, Metzeler KH, Huang X, Kohlschmidt J, Mendler JH, Benito JM, Hickey C, Neviani P, Dorrance AM, Anghelina M, Khalife J, Tarighat SS, Volinia S, et al. SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome. The Journal of Clinical Investigation. 124: 1512-24. PMID 24590286 DOI: 10.1172/Jci70921 |
0.586 |
|
| 2013 |
Bernot KM, Nemer JS, Santhanam R, Liu S, Zorko NA, Whitman SP, Dickerson KE, Zhang M, Yang X, McConnell KK, Ahmed EH, Muñoz MR, Siebenaler RF, Marcucci GG, Mundy-Bosse BL, ... ... Dorrance AM, et al. Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease. Blood. 122: 3778-83. PMID 24085765 DOI: 10.1182/Blood-2013-06-507426 |
0.572 |
|
| 2013 |
Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, Ma Y, Mao HC, Zhang B, Wunderlich M, May PC, et al. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. The Journal of Clinical Investigation. 123: 4144-57. PMID 23999433 DOI: 10.1172/Jci68951 |
0.515 |
|
| 2013 |
Bernot KM, Siebenaler RF, Whitman SP, Zorko NA, Marcucci GG, Santhanam R, Ahmed EH, Ngangana M, McConnell KK, Nemer JS, Brook DL, Kulp SK, Chen CS, Frankhouser D, Yan P, ... ... Dorrance AM, et al. Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML. Leukemia. 27: 2379-82. PMID 23660685 DOI: 10.1038/Leu.2013.147 |
0.492 |
|
| 2013 |
Dorrance AM, De Vita S, Radu M, Reddy PN, McGuinness MK, Harris CE, Mathieu R, Lane SW, Kosoff R, Milsom MD, Chernoff J, Williams DA. The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment. Blood. 121: 2474-82. PMID 23335370 DOI: 10.1182/Blood-2012-10-460709 |
0.409 |
|
| 2013 |
Mims A, Walker AR, Huang X, Sun J, Wang H, Santhanam R, Dorrance AM, Walker C, Hoellerbauer P, Tarighat SS, Chan KK, Klisovic RB, Perrotti D, Caligiuri MA, Byrd JC, et al. Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia. Leukemia. 27: 871-8. PMID 23178755 DOI: 10.1038/Leu.2012.342 |
0.522 |
|
| 2013 |
Hickey CJ, Schwind S, Radomska HS, Dorrance AM, Santhanam R, Mishra A, Wu YZ, Alachkar H, Maharry K, Nicolet D, Mrózek K, Walker A, Eiring AM, Whitman SP, Becker H, et al. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia. Blood. 121: 159-69. PMID 23100311 DOI: 10.1182/Blood-2012-05-428573 |
0.517 |
|
| 2013 |
Khalife JC, Radomska HS, Saultz J, Santhanam R, Huang X, Wang H, Curfman JP, Wu Y, Hoellerbauer P, Alachkar H, Dorrance AM, Caligiuri MA, Garzon R, Mendler JH, Marcucci G. Targeting Mir-155 via The NEDD8-Activating Enzyme Inhibitor MLN4924: A Novel Therapeutic Approach For Acute Myeloid Leukemia (AML) Blood. 122: 3804-3804. DOI: 10.1182/Blood.V122.21.3804.3804 |
0.551 |
|
| 2013 |
Bernot KM, Nemer JS, Santhanam R, Liu S, Marcucci GG, Zorko NA, Whitman SP, Yan P, Frankhouser D, Bundschuh R, Zhang M, Siebenaler RF, Ahmed EH, McConnell KK, Munoz M, ... ... Dorrance AM, et al. Abstract 3249: Targeting the miR29b/Sp1/Dnmt pathway for curative therapy in Mll-PTD/Flt3-ITD acute myeloid leukemia. Cancer Research. 73: 3249-3249. DOI: 10.1158/1538-7445.Am2013-3249 |
0.568 |
|
| 2012 |
Zorko NA, Bernot KM, Whitman SP, Siebenaler RF, Ahmed EH, Marcucci GG, Yanes DA, McConnell KK, Mao C, Kalu C, Zhang X, Jarjoura D, Dorrance AM, Heerema NA, Lee BH, et al. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias. Blood. 120: 1130-6. PMID 22674806 DOI: 10.1182/Blood-2012-03-415067 |
0.569 |
|
| 2012 |
Nieborowska-Skorska M, Kopinski PK, Ray R, Hoser G, Ngaba D, Flis S, Cramer K, Reddy MM, Koptyra M, Penserga T, Glodkowska-Mrowka E, Bolton E, Holyoake TL, Eaves CJ, Cerny-Reiterer S, ... ... Dorrance A, et al. Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood. 119: 4253-63. PMID 22411871 DOI: 10.1182/Blood-2011-10-385658 |
0.388 |
|
| 2012 |
Lane SW, De Vita S, Alexander KA, Karaman R, Milsom MD, Dorrance AM, Purdon A, Louis L, Bouxsein ML, Williams DA. Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development. Blood. 119: 736-44. PMID 22123845 DOI: 10.1182/Blood-2011-07-368753 |
0.404 |
|
| 2012 |
Alachkar H, Maharry K, Santhanam R, Neviani P, Volinia S, Kohlschmidt J, Metzeler KH, Dorrance AM, Schwind S, Becker H, Mendler JH, Eisfeld A, Whitman S, Mrózek K, Garzon R, et al. SPARC contributes to Leukemia Growth and Aggressive Disease in Acute Myeloid Leukemia (AML) Blood. 120: 773-773. DOI: 10.1182/Blood.V120.21.773.773 |
0.578 |
|
| 2011 |
Sanchez-Aguilera A, Lee YJ, Lo Celso C, Ferraro F, Brumme K, Mondal S, Kim C, Dorrance A, Luo HR, Scadden DT, Williams DA. Guanine nucleotide exchange factor Vav1 regulates perivascular homing and bone marrow retention of hematopoietic stem and progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 9607-12. PMID 21606370 DOI: 10.1073/Pnas.1102018108 |
0.384 |
|
| 2010 |
Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA. In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 184: 2769-75. PMID 20142363 DOI: 10.4049/Jimmunol.0900685 |
0.716 |
|
| 2008 |
Dorrance AM, Liu S, Chong A, Pulley B, Nemer D, Guimond M, Yuan W, Chang D, Whitman SP, Marcucci G, Caligiuri MA. The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele. Blood. 112: 2508-11. PMID 18617636 DOI: 10.1182/Blood-2008-01-134338 |
0.557 |
|
| 2007 |
Guimond M, Freud AG, Mao HC, Blaser BW, Lagemann GG, Vandeusen JB, Dorrance A, Ferketich AK, Cavalcanti M, Mackall CL, Caligiuri MA. Mechanism by Which Exogenous Administration of Flt3 Ligand (FL) Expands Natural Killer Cells In Vivo. Blood. 110: 2310-2310. DOI: 10.1182/Blood.V110.11.2310.2310 |
0.722 |
|
| 2006 |
Dorrance AM, Liu S, Yuan W, Becknell B, Arnoczky KJ, Guimond M, Strout MP, Feng L, Nakamura T, Yu L, Rush LJ, Weinstein M, Leone G, Wu L, Ferketich A, et al. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. The Journal of Clinical Investigation. 116: 2707-16. PMID 16981007 DOI: 10.1172/Jci25546 |
0.709 |
|
| 2005 |
Whitman SP, Liu S, Vukosavljevic T, Rush LJ, Yu L, Liu C, Klisovic MI, Maharry K, Guimond M, Strout MP, Becknell B, Dorrance A, Klisovic RB, Plass C, Bloomfield CD, et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood. 106: 345-52. PMID 15774615 DOI: 10.1182/Blood-2005-01-0204 |
0.713 |
|
| Show low-probability matches. |